Sally J. Dawson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sally J. Dawson has a total of 358 co-authors. Here are the top co-authors by number of shared publications:
David S. Latchman
15 shared publications- Jonathan E. Gale
UCL Ear Institute, 332 Gray's Inn Road, London WC1X 8EE, UK
7 shared publications - Frances M. K. Williams
Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King’s College London, London, UK
6 shared publications - Michael R. Bowl
UCL Ear Institute, University College London, London, UK
6 shared publications Peter J. Morris
6 shared publicationsLisa S. Nolan
UCL Ear Institute, London, UK
5 shared publications
Latest Publications
- Open Access
- 17 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Cross-species validation of a human age-related hearing loss candidate KLHDC7B as essential for mammalian hearing
Although age-related hearing loss (ARHL) is the most common sensory loss in older adults, underlying mechanisms remain unclear. Recent genome-wide association studies (GWAS) linked variation in several genes with ARHL risk, including KLHDC7B , a gene of unknown function not previously linked to hearing. We demonstrate Klhdc7b is expressed exclusively in sensory hair cells in mouse cochlea. Utilizing two independent mouse knockout models ( Klhdc7b IMPC-/- and Klhdc7b Regn Δ/Δ ) we find that absence of Klhdc7b leads to severe early-onset, progressive hearing loss. Hair cells appear to develop normally, but outer hair cells are progressively lost from base-to-apex of the cochlea, a common pathology in ARHL. These results suggest KLHDC7B is required for maintenance rather than development, of auditory function. The validation in mouse of a human ARHL GWAS association suggests other novel candidates should be investigated. Our work provides two mouse models to study KLHDC7B function, and for development of therapeutic tools for ARHL.
- 17 December 2025
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessCross-species validation of a human age-related hearing loss candidate KLHDC7B as essential for mammalian hearing
Although age-related hearing loss (ARHL) is the most common sensory loss in older adults, underlying mechanisms remain unclear. Recent genome-wide association studies (GWAS) linked variation in several genes with ARHL risk, including KLHDC7B , a gene of unknown function not previously linked to hearing. We demonstrate Klhdc7b is expressed exclusively in sensory hair cells in mouse cochlea. Utilizing two independent mouse knockout models ( Klhdc7b IMPC-/- and Klhdc7b Regn Δ/Δ ) we find that absence of Klhdc7b leads to severe early-onset, progressive hearing loss. Hair cells appear to develop normally, but outer hair cells are progressively lost from base-to-apex of the cochlea, a common pathology in ARHL. These results suggest KLHDC7B is required for maintenance rather than development, of auditory function. The validation in mouse of a human ARHL GWAS association suggests other novel candidates should be investigated. Our work provides two mouse models to study KLHDC7B function, and for development of therapeutic tools for ARHL.
- Open Access
- 30 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf203
Distinct changes in the morphology of cortical and subcortical grey matter associated with age-related hearing loss and tinnitus in the UK Biobank participants
Prevalence of both hearing loss and tinnitus increases with age. However, neuroimaging studies of both conditions report inconsistent changes in brain morphology likely due to small sample size and variable methodology. Structural and functional neuroimaging studies in hearing loss and tinnitus have revealed distinct neural correlates, and further replication is needed to confirm these findings. This study aims to investigate the effects of hearing loss and tinnitus on the brain morphology in a well-powered sample. We utilized self-reported hearing difficulty and tinnitus in participants with magnetic resonance imaging (MRI) in the UK Biobank cohort. Control participants without hearing difficulty and tinnitus were age and sex matched leading to total sample sizes of 13 074 and 6242 for self-reported hearing difficulty and tinnitus, respectively. We utilized the rich UK Biobank dataset (i) to reveal these brain changes in a well-powered large study of hearing loss and tinnitus, (ii) to document the effect of confounding factors on these associations, (iii) to discriminate the effects of tinnitus versus hearing difficulty on the brain and (iv) to estimate the brain-age gap in hearing difficulty and tinnitus subjects compared with controls. Hearing difficulty is significantly associated with smaller grey matter volumes exclusively in the bilateral transverse temporal regions, whereas tinnitus is associated with larger volumes of bilateral hippocampi and thalami when compared with the control group. Furthermore, correcting for confounders (i.e. diabetes, cardiovascular disease, age, sex, smoking, alcohol consumption and Townsend deprivation index) during statistical analysis helped to better delineate the impact of hearing status on brain structural changes. The brain-age gap analysis showed that participants with tinnitus appeared to have significantly younger brains than controls, whereas participants with hearing difficulty did not differ significantly from the control group. Altogether, our results confirmed previous findings and suggest the enlargement of bilateral thalami as the main effect in people with tinnitus. We also established that there are independent and distinct brain pathologies between hearing difficulty and tinnitus. Therefore, the self-reported measure is a reasonable approach to assess the hearing loss and tinnitus pathologies.
- 30 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf203
Open AccessDistinct changes in the morphology of cortical and subcortical grey matter associated with age-related hearing loss and tinnitus in the UK Biobank participants
Prevalence of both hearing loss and tinnitus increases with age. However, neuroimaging studies of both conditions report inconsistent changes in brain morphology likely due to small sample size and variable methodology. Structural and functional neuroimaging studies in hearing loss and tinnitus have revealed distinct neural correlates, and further replication is needed to confirm these findings. This study aims to investigate the effects of hearing loss and tinnitus on the brain morphology in a well-powered sample. We utilized self-reported hearing difficulty and tinnitus in participants with magnetic resonance imaging (MRI) in the UK Biobank cohort. Control participants without hearing difficulty and tinnitus were age and sex matched leading to total sample sizes of 13 074 and 6242 for self-reported hearing difficulty and tinnitus, respectively. We utilized the rich UK Biobank dataset (i) to reveal these brain changes in a well-powered large study of hearing loss and tinnitus, (ii) to document the effect of confounding factors on these associations, (iii) to discriminate the effects of tinnitus versus hearing difficulty on the brain and (iv) to estimate the brain-age gap in hearing difficulty and tinnitus subjects compared with controls. Hearing difficulty is significantly associated with smaller grey matter volumes exclusively in the bilateral transverse temporal regions, whereas tinnitus is associated with larger volumes of bilateral hippocampi and thalami when compared with the control group. Furthermore, correcting for confounders (i.e. diabetes, cardiovascular disease, age, sex, smoking, alcohol consumption and Townsend deprivation index) during statistical analysis helped to better delineate the impact of hearing status on brain structural changes. The brain-age gap analysis showed that participants with tinnitus appeared to have significantly younger brains than controls, whereas participants with hearing difficulty did not differ significantly from the control group. Altogether, our results confirmed previous findings and suggest the enlargement of bilateral thalami as the main effect in people with tinnitus. We also established that there are independent and distinct brain pathologies between hearing difficulty and tinnitus. Therefore, the self-reported measure is a reasonable approach to assess the hearing loss and tinnitus pathologies.
- Open Access
- 26 February 2025
- Published by Springer Nature in Nature
- p. 1-9
Rare disease gene association discovery in the 100,000 Genomes Project
Up to 80% of rare disease patients remain undiagnosed after genomic sequencing 1 , with many probably involving pathogenic variants in yet to be discovered disease–gene associations. To search for such associations, we developed a rare variant gene burden analytical framework for Mendelian diseases, and applied it to protein-coding variants from whole-genome sequencing of 34,851 cases and their family members recruited to the 100,000 Genomes Project 2 . A total of 141 new associations were identified, including five for which independent disease–gene evidence was recently published. Following in silico triaging and clinical expert review, 69 associations were prioritized, of which 30 could be linked to existing experimental evidence. The five associations with strongest overall genetic and experimental evidence were monogenic diabetes with the known β cell regulator 3,4 UNC13A , schizophrenia with GPR17 , epilepsy with RBFOX3 , Charcot–Marie–Tooth disease with ARPC3 and anterior segment ocular abnormalities with POMK . Further confirmation of these and other associations could lead to numerous diagnoses, highlighting the clinical impact of large-scale statistical approaches to rare disease–gene association discovery.
- 26 February 2025
- Published by Springer Nature in Nature
- p. 1-9
Open AccessRare disease gene association discovery in the 100,000 Genomes Project
Up to 80% of rare disease patients remain undiagnosed after genomic sequencing 1 , with many probably involving pathogenic variants in yet to be discovered disease–gene associations. To search for such associations, we developed a rare variant gene burden analytical framework for Mendelian diseases, and applied it to protein-coding variants from whole-genome sequencing of 34,851 cases and their family members recruited to the 100,000 Genomes Project 2 . A total of 141 new associations were identified, including five for which independent disease–gene evidence was recently published. Following in silico triaging and clinical expert review, 69 associations were prioritized, of which 30 could be linked to existing experimental evidence. The five associations with strongest overall genetic and experimental evidence were monogenic diabetes with the known β cell regulator 3,4 UNC13A , schizophrenia with GPR17 , epilepsy with RBFOX3 , Charcot–Marie–Tooth disease with ARPC3 and anterior segment ocular abnormalities with POMK . Further confirmation of these and other associations could lead to numerous diagnoses, highlighting the clinical impact of large-scale statistical approaches to rare disease–gene association discovery.
- Open Access
The genomic landscape of syndromic and non-syndromic hearing loss within the 100,000 Genomes Project cohort
Objective: This study aims to describe the genetic landscape of syndromic and non-syndromic hearing loss (HL) in the UK population using data from the 100,000 Genomes Project (100kGP). Design: Cohort study Setting: NHS England Participants: 2,271 families with syndromic and non-syndromic HL recruited to the 100kGP rare disease programme between 2013 and 2018. Participants with at least one Human Phenotype Ontology (HPO) term descendant of the term “Hearing impairment” (HP:0000365) were included; this equated to 5,488 individuals, comprising 2,762 affected individuals and 2,726 unaffected relatives. Main outcome measure: Diagnostic rate and prevalence of different gene diagnoses by auditory phenotype identified by whole genome sequencing. Results: The overall diagnostic yield was conservatively estimated at 27.5% (625/2271), with diagnoses identified in 273 different genes. Common causative genes included USH2A, GJB2, COL1A1 and MYO15A , accounting for approximately 20% of the diagnoses. This diagnostic rate excludes variants of uncertain significance (VUS), variants in genes where HL cannot be confidently attributed to the identified variant, or those still awaiting confirmation. The inclusion of these categories would increase the diagnostic yield to 39.6%. This work describes the 100kGP standard pipeline and supplementary analyses that include the use of Exomiser. Stratification of the cohort allowed quantification of the likelihood of genetic diagnosis with specific phenotypic combinations and identification of positive predictors for a genetic diagnosis by auditory phenotype. A statistically significant increase in diagnostic rate was reported for those with congenital (33.2%), bilateral (27%), and high-frequency (32.4%) hearing subtypes. Furthermore, in patients with HPO terms restricted to the auditory system alone, around 40% of diagnoses were attributed to genes that might have a broader syndromic phenotype (non-syndromic mimics). A high diagnostic yield (56%) was seen in patients with ear and eye abnormalities, largely driven by genes associated with Usher and Wolfram syndrome. Conclusion: In conclusion, this study offers valuable insights into the complex genomic and phenotypic architecture of both syndromic and non-syndromic HL, which has the potential to improve diagnostic pipelines and inform clinical care.
Open AccessThe genomic landscape of syndromic and non-syndromic hearing loss within the 100,000 Genomes Project cohort
Objective: This study aims to describe the genetic landscape of syndromic and non-syndromic hearing loss (HL) in the UK population using data from the 100,000 Genomes Project (100kGP). Design: Cohort study Setting: NHS England Participants: 2,271 families with syndromic and non-syndromic HL recruited to the 100kGP rare disease programme between 2013 and 2018. Participants with at least one Human Phenotype Ontology (HPO) term descendant of the term “Hearing impairment” (HP:0000365) were included; this equated to 5,488 individuals, comprising 2,762 affected individuals and 2,726 unaffected relatives. Main outcome measure: Diagnostic rate and prevalence of different gene diagnoses by auditory phenotype identified by whole genome sequencing. Results: The overall diagnostic yield was conservatively estimated at 27.5% (625/2271), with diagnoses identified in 273 different genes. Common causative genes included USH2A, GJB2, COL1A1 and MYO15A , accounting for approximately 20% of the diagnoses. This diagnostic rate excludes variants of uncertain significance (VUS), variants in genes where HL cannot be confidently attributed to the identified variant, or those still awaiting confirmation. The inclusion of these categories would increase the diagnostic yield to 39.6%. This work describes the 100kGP standard pipeline and supplementary analyses that include the use of Exomiser. Stratification of the cohort allowed quantification of the likelihood of genetic diagnosis with specific phenotypic combinations and identification of positive predictors for a genetic diagnosis by auditory phenotype. A statistically significant increase in diagnostic rate was reported for those with congenital (33.2%), bilateral (27%), and high-frequency (32.4%) hearing subtypes. Furthermore, in patients with HPO terms restricted to the auditory system alone, around 40% of diagnoses were attributed to genes that might have a broader syndromic phenotype (non-syndromic mimics). A high diagnostic yield (56%) was seen in patients with ear and eye abnormalities, largely driven by genes associated with Usher and Wolfram syndrome. Conclusion: In conclusion, this study offers valuable insights into the complex genomic and phenotypic architecture of both syndromic and non-syndromic HL, which has the potential to improve diagnostic pipelines and inform clinical care.
- Open Access
KLHDC7B, a novel gene associated with age-related hearing loss in humans, is required for the maintenance of hearing in mice
Background: Age-related hearing loss (ARHL) is the most common sensory loss in older adults, but the underlying pathological mechanisms remain unclear. Recent genome wide association studies (GWAS) have linked variation in a large number of genes with increased risk of ARHL for the first time. Amongst the strongest of these associations is variation in KLHDC7B, a gene of unknown function and one not previously linked to hearing. Methods: To confirm whether KLHDC7B plays a role in hearing we investigated auditory function in two independent knockout mutant mouse models of Klhdc7b: Klhdc7b IMPC−/− and Klhdc7b RegnΔ/Δ on the C57BL/6N background and the B6.CAST- Cdh23 753A>G background respectively. The B6.CAST- Cdh23 753A>G background was backcrossed to correct a known age-related hearing loss ( ahl ) mutation in cadherin 23 present in both the C57BL/6N and C57BL/6J strains. Results: We showed that Klhdc7b is expressed exclusively in inner and outer sensory hair cells within the cochlea of mice at the RNA and protein level. Homozygous mutants for both knockout mouse models display a similar early-onset, progressive and severe hearing loss. Histological characterization of the two mouse models suggests that hair cells develop normally and are present in neonates. However, after the onset of hearing there is a progressive loss of outer hair cells in a gradient from base to apex of the cochlea consistent with the hearing deficit in the mice and the pattern of hearing loss in ARHL. Inner hair cells remain intact up to the latest age examined (~8 weeks). Conclusions: Our data suggests KLHDC7B is required for maintenance of auditory function rather than in its development, supporting the novel association with ARHL in humans detected in recent GWAS. To our knowledge, this is the first validation in mouse of an ARHL association in humans detected in a GWAS. Our work also provides two distinct mouse models to further investigate the role of KLHDC7B in auditory function and for use in the development of therapeutic tools to prevent or treat ARHL.
Open AccessKLHDC7B, a novel gene associated with age-related hearing loss in humans, is required for the maintenance of hearing in mice
Background: Age-related hearing loss (ARHL) is the most common sensory loss in older adults, but the underlying pathological mechanisms remain unclear. Recent genome wide association studies (GWAS) have linked variation in a large number of genes with increased risk of ARHL for the first time. Amongst the strongest of these associations is variation in KLHDC7B, a gene of unknown function and one not previously linked to hearing. Methods: To confirm whether KLHDC7B plays a role in hearing we investigated auditory function in two independent knockout mutant mouse models of Klhdc7b: Klhdc7b IMPC−/− and Klhdc7b RegnΔ/Δ on the C57BL/6N background and the B6.CAST- Cdh23 753A>G background respectively. The B6.CAST- Cdh23 753A>G background was backcrossed to correct a known age-related hearing loss ( ahl ) mutation in cadherin 23 present in both the C57BL/6N and C57BL/6J strains. Results: We showed that Klhdc7b is expressed exclusively in inner and outer sensory hair cells within the cochlea of mice at the RNA and protein level. Homozygous mutants for both knockout mouse models display a similar early-onset, progressive and severe hearing loss. Histological characterization of the two mouse models suggests that hair cells develop normally and are present in neonates. However, after the onset of hearing there is a progressive loss of outer hair cells in a gradient from base to apex of the cochlea consistent with the hearing deficit in the mice and the pattern of hearing loss in ARHL. Inner hair cells remain intact up to the latest age examined (~8 weeks). Conclusions: Our data suggests KLHDC7B is required for maintenance of auditory function rather than in its development, supporting the novel association with ARHL in humans detected in recent GWAS. To our knowledge, this is the first validation in mouse of an ARHL association in humans detected in a GWAS. Our work also provides two distinct mouse models to further investigate the role of KLHDC7B in auditory function and for use in the development of therapeutic tools to prevent or treat ARHL.
- Open Access
- 15 July 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (14)
The ototoxic drug cisplatin localises to stress granules altering their dynamics and composition
Cisplatin is an effective platinum-based chemotherapeutic with several side effects, including ototoxicity. Cochlear cells have low rates of proliferation yet are highly susceptible to cisplatin. We hypothesised that cisplatin ototoxicity might be caused by cisplatin–protein interactions rather than cisplatin–DNA interactions. Two known cisplatin-binding proteins are involved in the stress granule (SG) response. SGs are a pro-survival mechanism involving formation of transient ribonucleoprotein complexes during stress. We examined the effects of cisplatin on SG dynamics and composition in cell lines derived from the cochlea and retinal pigment epithelium. Cisplatin-induced SGs are significantly diminished in size and quantity compared to arsenite-induced SGs and are persistent after 24 h recovery. Additionally, cisplatin pre-treated cells were unable to form a typical SG response to subsequent arsenite stress. Cisplatin-induced SGs had significant reductions in the sequestration of eIF4G and the proteins RACK1 and DDX3X. Live-cell imaging of Texas Red-conjugated cisplatin revealed its localisation to SGs and retention for at least 24 h. We show cisplatin-induced SGs have impaired assembly, altered composition and are persistent, providing evidence of an alternate mechanism for cisplatin-induced ototoxicity via an impaired SG response.
- 15 July 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (14)
Open AccessThe ototoxic drug cisplatin localises to stress granules altering their dynamics and composition
Cisplatin is an effective platinum-based chemotherapeutic with several side effects, including ototoxicity. Cochlear cells have low rates of proliferation yet are highly susceptible to cisplatin. We hypothesised that cisplatin ototoxicity might be caused by cisplatin–protein interactions rather than cisplatin–DNA interactions. Two known cisplatin-binding proteins are involved in the stress granule (SG) response. SGs are a pro-survival mechanism involving formation of transient ribonucleoprotein complexes during stress. We examined the effects of cisplatin on SG dynamics and composition in cell lines derived from the cochlea and retinal pigment epithelium. Cisplatin-induced SGs are significantly diminished in size and quantity compared to arsenite-induced SGs and are persistent after 24 h recovery. Additionally, cisplatin pre-treated cells were unable to form a typical SG response to subsequent arsenite stress. Cisplatin-induced SGs had significant reductions in the sequestration of eIF4G and the proteins RACK1 and DDX3X. Live-cell imaging of Texas Red-conjugated cisplatin revealed its localisation to SGs and retention for at least 24 h. We show cisplatin-induced SGs have impaired assembly, altered composition and are persistent, providing evidence of an alternate mechanism for cisplatin-induced ototoxicity via an impaired SG response.
- Open Access
- 21 October 2022
- Published by Elsevier in Hearing Research
- Vol. 426, 108634
An emerging role for stress granules in neurodegenerative disease and hearing loss
- 21 October 2022
- Published by Elsevier in Hearing Research
- Vol. 426, 108634
Open AccessAn emerging role for stress granules in neurodegenerative disease and hearing loss
- Open Access
- 14 February 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-16
Targeted deletion of the RNA-binding protein Caprin1 leads to progressive hearing loss and impairs recovery from noise exposure in mice
Cell cycle associated protein 1 (Caprin1) is an RNA-binding protein that can regulate the cellular post-transcriptional response to stress. It is a component of both stress granules and neuronal RNA granules and is implicated in neurodegenerative disease, synaptic plasticity and long-term memory formation. Our previous work suggested that Caprin1 also plays a role in the response of the cochlea to stress. Here, targeted inner ear-deletion of Caprin1 in mice leads to an early onset, progressive hearing loss. Auditory brainstem responses from Caprin1-deficient mice show reduced thresholds, with a significant reduction in wave-I amplitudes compared to wildtype. Whilst hair cell structure and numbers were normal, the inner hair cell-spiral ganglion neuron (IHC-SGN) synapse revealed abnormally large post-synaptic GluA2 receptor puncta, a defect consistent with the observed wave-I reduction. Unlike wildtype mice, mild-noise-induced hearing threshold shifts in Caprin1-deficient mice did not recover. Oxidative stress triggered TIA-1/HuR-positive stress granule formation in ex-vivo cochlear explants from Caprin1-deficient mice, showing that stress granules could still be induced. Taken together, these findings suggest that Caprin1 plays a key role in maintenance of auditory function, where it regulates the normal status of the IHC-SGN synapse.
- 14 February 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-16
Open AccessTargeted deletion of the RNA-binding protein Caprin1 leads to progressive hearing loss and impairs recovery from noise exposure in mice
Cell cycle associated protein 1 (Caprin1) is an RNA-binding protein that can regulate the cellular post-transcriptional response to stress. It is a component of both stress granules and neuronal RNA granules and is implicated in neurodegenerative disease, synaptic plasticity and long-term memory formation. Our previous work suggested that Caprin1 also plays a role in the response of the cochlea to stress. Here, targeted inner ear-deletion of Caprin1 in mice leads to an early onset, progressive hearing loss. Auditory brainstem responses from Caprin1-deficient mice show reduced thresholds, with a significant reduction in wave-I amplitudes compared to wildtype. Whilst hair cell structure and numbers were normal, the inner hair cell-spiral ganglion neuron (IHC-SGN) synapse revealed abnormally large post-synaptic GluA2 receptor puncta, a defect consistent with the observed wave-I reduction. Unlike wildtype mice, mild-noise-induced hearing threshold shifts in Caprin1-deficient mice did not recover. Oxidative stress triggered TIA-1/HuR-positive stress granule formation in ex-vivo cochlear explants from Caprin1-deficient mice, showing that stress granules could still be induced. Taken together, these findings suggest that Caprin1 plays a key role in maintenance of auditory function, where it regulates the normal status of the IHC-SGN synapse.
- Open Access
- 29 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Differential regulation of mammalian and avian ATOH1 by E2F1 and its implication for hair cell regeneration in the inner ear
The mammalian inner ear has a limited capacity to regenerate its mechanosensory hair cells. This lack of regenerative capacity underlies the high incidence of age-related hearing loss in humans. In contrast, non-mammalian vertebrates can form new hair cells when damage occurs, a mechanism that depends on re-activation of expression of the pro-hair cell transcription factorAtoh1. Here, we show that members of the E2F transcription factor family, known to play a key role in cell cycle progression, regulate the expression ofAtoh1. E2F1 activates chickenAtoh1by directly interacting with a cis-regulatory region distal to the avianAtoh1gene. E2F does not activate mouseAtoh1gene expression, since this regulatory element is absent in mammals. We also show that E2F1 expression changes dynamically in the chicken auditory epithelium during ototoxic damage and hair cell regeneration. Therefore, we propose a model in which the mitotic regeneration of non-mammalian hair cells is due to E2F1-mediated activation ofAtoh1expression, a mechanism which has been lost in mammals.
- 29 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Open AccessDifferential regulation of mammalian and avian ATOH1 by E2F1 and its implication for hair cell regeneration in the inner ear
The mammalian inner ear has a limited capacity to regenerate its mechanosensory hair cells. This lack of regenerative capacity underlies the high incidence of age-related hearing loss in humans. In contrast, non-mammalian vertebrates can form new hair cells when damage occurs, a mechanism that depends on re-activation of expression of the pro-hair cell transcription factorAtoh1. Here, we show that members of the E2F transcription factor family, known to play a key role in cell cycle progression, regulate the expression ofAtoh1. E2F1 activates chickenAtoh1by directly interacting with a cis-regulatory region distal to the avianAtoh1gene. E2F does not activate mouseAtoh1gene expression, since this regulatory element is absent in mammals. We also show that E2F1 expression changes dynamically in the chicken auditory epithelium during ototoxic damage and hair cell regeneration. Therefore, we propose a model in which the mitotic regeneration of non-mammalian hair cells is due to E2F1-mediated activation ofAtoh1expression, a mechanism which has been lost in mammals.
- Open Access
- 22 July 2021
- Published by Springer Nature in npj Aging and Mechanisms of Disease
- Vol. 7 (1) , 1-8
Hearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture
Age-related hearing loss was recently established as the largest modifiable risk factor for Alzheimer’s disease (AD), however, the reasons for this link remain unclear. We investigate shared underlying genetic associations using results from recent large genome-wide association studies (GWAS) on adult hearing difficulty and AD. Genetic correlation and Mendelian randomization (MR) analysis do not support a genetic correlation between the disorders, but suggest a direct causal link from AD genetic risk to hearing difficulty, driven by APOE. Systematic MR analyses on the effect of other traits revealed shared effects of glutamine, gamma-glutamylglutamine, and citrate levels on reduced risk of both hearing difficulty and AD. In addition, pathway analysis on GWAS risk variants suggests shared function in neuronal signalling pathways as well as etiology of diabetes and cardiovascular disease. However, after multiple testing corrections, neither analysis led to statistically significant associations. Altogether, our genetic-driven analysis suggests hearing difficulty and AD are linked by a shared vulnerability in molecular pathways rather than by a shared genetic architecture.
- 22 July 2021
- Published by Springer Nature in npj Aging and Mechanisms of Disease
- Vol. 7 (1) , 1-8
Open AccessHearing difficulty is linked to Alzheimer’s disease by common genetic vulnerability, not shared genetic architecture
Age-related hearing loss was recently established as the largest modifiable risk factor for Alzheimer’s disease (AD), however, the reasons for this link remain unclear. We investigate shared underlying genetic associations using results from recent large genome-wide association studies (GWAS) on adult hearing difficulty and AD. Genetic correlation and Mendelian randomization (MR) analysis do not support a genetic correlation between the disorders, but suggest a direct causal link from AD genetic risk to hearing difficulty, driven by APOE. Systematic MR analyses on the effect of other traits revealed shared effects of glutamine, gamma-glutamylglutamine, and citrate levels on reduced risk of both hearing difficulty and AD. In addition, pathway analysis on GWAS risk variants suggests shared function in neuronal signalling pathways as well as etiology of diabetes and cardiovascular disease. However, after multiple testing corrections, neither analysis led to statistically significant associations. Altogether, our genetic-driven analysis suggests hearing difficulty and AD are linked by a shared vulnerability in molecular pathways rather than by a shared genetic architecture.